BG106638A - Нови циклопропани като cgrp-антагонисти, лекарствени средства, които ги съдържат и метод за получаването им - Google Patents

Нови циклопропани като cgrp-антагонисти, лекарствени средства, които ги съдържат и метод за получаването им Download PDF

Info

Publication number
BG106638A
BG106638A BG106638A BG10663802A BG106638A BG 106638 A BG106638 A BG 106638A BG 106638 A BG106638 A BG 106638A BG 10663802 A BG10663802 A BG 10663802A BG 106638 A BG106638 A BG 106638A
Authority
BG
Bulgaria
Prior art keywords
amino
groups
carbonyl
dihydro
general formula
Prior art date
Application number
BG106638A
Other languages
Bulgarian (bg)
English (en)
Inventor
Wolfgang Eberlein
Wolfhard Engel
Klaus Rudolf
Henri Doods
Gerhard Hallermayer
Eckhart Bauer
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of BG106638A publication Critical patent/BG106638A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
BG106638A 1999-10-29 2002-04-23 Нови циклопропани като cgrp-антагонисти, лекарствени средства, които ги съдържат и метод за получаването им BG106638A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19952147A DE19952147A1 (de) 1999-10-29 1999-10-29 Neue Cyclopropane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
PCT/EP2000/010391 WO2001032648A1 (de) 1999-10-29 2000-10-21 Neue cyclopropane als cgrp-antagonisten, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
BG106638A true BG106638A (bg) 2003-01-31

Family

ID=7927315

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106638A BG106638A (bg) 1999-10-29 2002-04-23 Нови циклопропани като cgrp-антагонисти, лекарствени средства, които ги съдържат и метод за получаването им

Country Status (26)

Country Link
US (2) US20030139417A1 (cs)
EP (1) EP1228059B1 (cs)
JP (1) JP3869721B2 (cs)
KR (1) KR20020047290A (cs)
CN (1) CN1177844C (cs)
AT (1) ATE301117T1 (cs)
AU (1) AU781856B2 (cs)
BG (1) BG106638A (cs)
BR (1) BR0015147A (cs)
CA (1) CA2387134C (cs)
CZ (1) CZ20021812A3 (cs)
DE (2) DE19952147A1 (cs)
EA (1) EA005137B1 (cs)
EE (1) EE200200220A (cs)
HR (1) HRP20020373A2 (cs)
HU (1) HUP0203496A3 (cs)
IL (1) IL148975A0 (cs)
MX (1) MXPA02004119A (cs)
NO (1) NO20021799D0 (cs)
NZ (1) NZ518698A (cs)
PL (1) PL354715A1 (cs)
SK (1) SK7282002A3 (cs)
TR (1) TR200201168T2 (cs)
WO (1) WO2001032648A1 (cs)
YU (1) YU30902A (cs)
ZA (1) ZA200203256B (cs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220862B2 (en) 2002-06-05 2007-05-22 Bristol-Myers Squibb Company Calcitonin gene related peptide receptor antagonists
US7842808B2 (en) 2002-06-05 2010-11-30 Bristol-Myers Squibb Company Anti-migraine spirocycles
RS52552B (sr) * 2002-06-05 2013-04-30 Bristol-Myers Squibb Company Antagonisti, peptidnog receptora koji je u vezi sa kalcitoninskim genom
TW200524601A (en) 2003-12-05 2005-08-01 Bristol Myers Squibb Co Heterocyclic anti-migraine agents
RS20060382A (sr) 2003-12-05 2008-09-29 Bristol-Myers Squibb Company, Antagonisti receptora za peptid povezan sa genom za kalcitonin
TW200533398A (en) 2004-03-29 2005-10-16 Bristol Myers Squibb Co Novel therapeutic agents for the treatment of migraine
EP1794133B1 (en) * 2004-09-09 2011-12-14 Merck Sharp & Dohme Corp. Aryl spirolactam cgrp receptor antagonists
US7384931B2 (en) 2004-11-03 2008-06-10 Bristol-Myers Squibb Company Constrained compounds as CGRP-receptor antagonists
US7384930B2 (en) 2004-11-03 2008-06-10 Bristol-Myers Squibb Company Constrained compounds as CGRP-receptor antagonists
US7449586B2 (en) 2004-12-03 2008-11-11 Bristol-Myers Squibb Company Processes for the preparation of CGRP-receptor antagonists and intermediates thereof
US7834007B2 (en) 2005-08-25 2010-11-16 Bristol-Myers Squibb Company CGRP antagonists
WO2007061677A2 (en) * 2005-11-18 2007-05-31 Merck & Co., Inc. Spirolactam aryl cgrp receptor antagonists
WO2009034029A2 (de) * 2007-09-07 2009-03-19 Boehringer Ingelheim International Gmbh 1-substituierte 4 -heterocyclylpiperidine als cgrp antagonisten
EP2065381A1 (de) 2007-10-18 2009-06-03 Boehringer Ingelheim Pharma GmbH & Co. KG CGRP Antagonisten
KR20100091972A (ko) 2007-10-18 2010-08-19 베링거 인겔하임 인터내셔날 게엠베하 Ｃｇｒｐ 길항제
US8829006B2 (en) 2007-11-22 2014-09-09 Boehringer Ingelheim International Gmbh Compounds
US9315449B2 (en) 2008-05-15 2016-04-19 Duke University Substituted pyrazoles as heat shock transcription factor activators
UA105182C2 (ru) 2008-07-03 2014-04-25 Ньюрексон, Інк. Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
KR20150000882A (ko) * 2012-04-05 2015-01-05 씨에이치디아이 파운데이션, 인코포레이티드 키뉴레닌-3-모노산소첨가효소 억제제들, 약학 조성물들 및 이의 사용 방법
ES2754473T3 (es) 2013-09-26 2020-04-17 Chdi Foundation Inc Inhibidores de quinurenina-3-monooxigenasa, composiciones farmacéuticas, y método de uso de los mismos
EP3049077A4 (en) 2013-09-26 2017-02-15 CHDI Foundation, Inc. Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
JP2019040859A (ja) * 2017-08-22 2019-03-14 株式会社エンプラス 発光装置、面光源装置および光束制御部材
CN114957145B (zh) * 2022-04-14 2023-07-18 浙江师范大学 一种1,2,4-苯并三嗪衍生物及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3655667A (en) * 1968-04-04 1972-04-11 Smith Kline French Lab 1-(2-benzoylcyclopropylmethyl)-4-phenylpiperazines
US3873707A (en) * 1972-10-02 1975-03-25 Robins Co Inc A H 1-Cyclopropyl-3-mono-(and 2,3-di) substituted-1-propanones in compositions and method for treating pain
FR2729855A1 (fr) 1995-01-26 1996-08-02 Oreal Utilisation d'un antagoniste de cgrp dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
IL124557A0 (en) 1995-12-15 1998-12-06 Novo Nordisk As Compositions for reducing blood glucose and/or inhibiting the activity of cgrp
WO1998009630A1 (en) * 1996-09-09 1998-03-12 Smithkline Beecham Corporation Compounds and methods
SK285631B6 (sk) 1996-09-10 2007-05-03 Dr. Karl Thomae Gmbh Modifikované aminokyseliny, farmaceutický prostriedok s ich obsahom a ich použitie
AU754830C (en) 1997-05-22 2004-02-12 G.D. Searle Llc Substituted pyrazoles as p38 kinase inhibitors
EP1071679A1 (en) * 1998-03-17 2001-01-31 Novo Nordisk A/S Novel heterocyclic compounds
DE19911039A1 (de) 1999-03-12 2000-09-14 Boehringer Ingelheim Pharma Abgewandelte Aminosäureamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
BR0009338A (pt) * 1999-03-26 2001-12-26 Astrazeneca Ab Composto, processo para a preparação do mesmo,composição farmacêutica, processo para apreparação da mesma, uso de um composto, e,método de tratamento de uma doençainflamatória em um paciente sofrendo ou em riscode dita doença
DE19937304C2 (de) 1999-08-10 2003-08-21 Boehringer Ingelheim Pharma Verwendung von CGRP-Antagonisten zur Bekämpfung menopausaler Hitzewallungen
US6696418B1 (en) * 1999-09-01 2004-02-24 Pfizer Inc. Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
TWI227231B (en) * 2000-07-12 2005-02-01 Novartis Ag 4-benzoyl-piperidine derivatives for treating conditions mediated by CCR-3
MXPA03004652A (es) * 2000-12-21 2003-09-05 Warner Lambert Co Derivados de piperidina como antagonistas selectivos de subtipo de n-metil-d-aspartato.
EP1441728A2 (en) * 2001-11-01 2004-08-04 Vertex Pharmaceuticals Incorporated Modulators of the cholesterol biosynthetic pathway
US6977265B2 (en) * 2001-11-30 2005-12-20 Roche Palo Alto Llc Piperidine CCR-3 receptor antagonists
US7026312B2 (en) * 2002-03-14 2006-04-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof

Also Published As

Publication number Publication date
CN1387526A (zh) 2002-12-25
YU30902A (sh) 2005-07-19
HK1051858A1 (en) 2003-08-22
MXPA02004119A (es) 2003-10-06
HUP0203496A3 (en) 2004-01-28
ZA200203256B (en) 2003-04-10
PL354715A1 (en) 2004-02-09
CA2387134A1 (en) 2001-05-10
JP2003513087A (ja) 2003-04-08
ATE301117T1 (de) 2005-08-15
IL148975A0 (en) 2002-11-10
US20030139417A1 (en) 2003-07-24
BR0015147A (pt) 2002-07-16
SK7282002A3 (en) 2002-11-06
EE200200220A (et) 2003-06-16
US20050267137A1 (en) 2005-12-01
NO20021799L (no) 2002-04-17
JP3869721B2 (ja) 2007-01-17
CA2387134C (en) 2008-07-08
CZ20021812A3 (cs) 2002-08-14
EP1228059A1 (de) 2002-08-07
EA200200447A1 (ru) 2002-10-31
HRP20020373A2 (en) 2003-10-31
NZ518698A (en) 2004-12-24
AU781856B2 (en) 2005-06-16
DE19952147A1 (de) 2001-05-03
EA005137B1 (ru) 2004-12-30
KR20020047290A (ko) 2002-06-21
EP1228059B1 (de) 2005-08-03
NO20021799D0 (no) 2002-04-17
HUP0203496A2 (hu) 2003-02-28
US7407963B2 (en) 2008-08-05
DE50010886D1 (de) 2005-09-08
WO2001032648A1 (de) 2001-05-10
TR200201168T2 (tr) 2002-08-21
AU7921300A (en) 2001-05-14
CN1177844C (zh) 2004-12-01

Similar Documents

Publication Publication Date Title
BG106638A (bg) Нови циклопропани като cgrp-антагонисти, лекарствени средства, които ги съдържат и метод за получаването им
KR102678264B1 (ko) 아펠린 수용체 효능제 및 사용 방법
TW200427681A (en) Selected cgrp antagonists, processes for preparing them and their use as pharmaceutical compositions
EP1300398A1 (en) Propane-1,3-dione derivatives
TW200413317A (en) Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
JP2003513088A (ja) アリールアルカン、アリールアルケン及びアリール−アザアルカン、これら化合物を含有する製薬組成物及びその調製方法
MX2007011527A (es) Nuevos antagonistas de cgrp, procedimiento para su preparacion, asi como su uso como medicamentos.
WO2003076432A1 (de) Benzodiazepin-substituierte piperdine zur verwendung in der behandlung von cardiovaskulären erkrankungen
US6716837B1 (en) Heterocyclic compounds for the treatment of migraine
JPWO2012036278A1 (ja) グリシントランスポーター阻害物質
MXPA02006509A (es) Nuevas piperidinas sustituidas, medicamentos que contienes estos compuestos y procedimientos para su preparacion.
CN103328442A (zh) 可用于治疗代谢性和炎性疾病的氮杂环丁烷衍生物
AU2013283487A1 (en) A phenyl triazole derivative and its use for modulating the GABAA receptor complex
WO2014001279A1 (en) A phenyl triazole derivative and its use for modulating the gabaa receptor complex
WO2004026837A2 (en) Histamine h3 receptor antagonists, preparaton and therapeutic uses
CN101198606A (zh) 作为ORL1-受体拮抗剂的α-(芳基-或杂芳基-甲基-)-β哌啶子基丙酰胺化合物
JP2021514372A (ja) デュアルの５−ｈｔ２ａおよび５−ｈｔ６受容体アンタゴニストとしての新しいインドールおよびベンゾイミダゾール誘導体
JP2001122784A (ja) １−［（１−置換−４−ピペリジニル）メチル］−４−ピペリジン誘導体からなる医薬
EA012590B1 (ru) 2-оксо-1,2,4,5-тетрагидро-1,3-бензодиазепин-3-илпиперидины в качестве cgrp-антагонистов